EUVIMEDEUVIMED entdecken
Open Access

Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients

Katherine T Lind iD, Kylene DeSmith, Brittany Marks, Arpita Deb, Gao Dexiang, Lauren C Mehner, Hesham Eissa

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Katherine T Lind und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Center for Cancer and Blood Disorders, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Retinitis, Cytomegalovirus, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Center Support Grant, NCATS NIH HHS, Cancer Center, University of Colorado.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cytomegalovirus (CMV) reactivation poses significant risks in pediatric patients undergoing allogeneic hematopoietic stem cell transplant (HSCT), including the potential for CMV retinitis, which can cause severe ocular complications. A previously published CMV retinitis screening protocol called for intensive and frequent screening exams with retinal photography.

Objectives

To evaluate the prevalence and incidence of CMV retinitis, assess institutional adherence to previously published protocol, and determine the impact and efficacy of the CMV retinitis screening protocol.

Methods

Retrospective cohort study of 228 patients treated at Children's Hospital Colorado from 2015 to 2021.

Results

Among allogeneic HSCT patients, 25.4% developed CMV viremia, and of these, three developed CMV retinitis (mean time from viremia to retinitis diagnosis: 53.6 days). Adherence to the protocol was suboptimal; 27.6% of patients with CMV viremia underwent recommended dilated fundus exam and photography within 2 weeks of diagnosis. Despite this, no significant long‐term ocular complications were noted, suggesting limited benefit from early and frequent screenings.

Conclusions

Within this cohort, 5.2% of patients with CMV viremia developed retinitis, and 15.4% of all patients developed at least one ocular complication. Universal pre‐HSCT screening with fundus photography did not result in early detection of retinitis. In this cohort, CMV retinitis did not develop until 5–12 weeks after viremia was detected, making early screening unlikely to have clinical significance. This study highlights the necessity of ocular screenings—as all patients with CMV retinitis were asymptomatic—but advocates for a more streamlined approach to improve adherence and protect ocular health during the vulnerable post‐transplant period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCytomegalovirus RetinitisCytomegalovirusMass ScreeningHumansRetrospective StudiesMaleFemaleChildChild, PreschoolAdolescentInfantFollow-Up StudiesIncidencePrognosisPrevalence

Stichwörter der Autor:innen

CMV retinitisophthalmologypediatric bone marrow transplantscreening

Autor:innen und Institutionen

  • Department of Pediatrics, Center for Cancer and Blood Disorders, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Cancer Center Biostatistical Core, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Katherine T Lind

Förderung

  • Cancer Center Support Grant
  • NCATS NIH HHS
  • Cancer Center, University of Colorado
  • NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Lind, K. T., DeSmith, K., Marks, B., Deb, A., Dexiang, G., Mehner, L. C., & Eissa, H. (2025). Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31910

Vancouver

Lind KT, DeSmith K, Marks B, Deb A, Dexiang G, Mehner LC, et al. Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31910

BibTeX
@article{Lind2025,
  author = {Lind, Katherine T and DeSmith, Kylene and Marks, Brittany and Deb, Arpita and Dexiang, Gao and Mehner, Lauren C and Eissa, Hesham},
  title = {Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31910}
}
Kostenlos starten →